Merger

Recorded: 2017-05-18 Pages: 14

View PDF Order Certified Copy

Assignor

MAZENCE INC.

Executed: 2007-01-18

Assignee

YUNGJIN PHARM. CO., LTD.

13 OLYMPIC-RO 35DA-GIL, SONGPA-GU, SEOUL, KOREA, REPUBLIC OF

Covered Property (1)

Novel Phenanthrenequinone-Based Compound and Pharmaceutical Composition Containing the Same for the Treatment or Prevention of Disease Involving Metabolic Syndrome

Patent: 8,404,869 →

Application: 12/597,414 →

Publication: US 2010/0137422

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.

Assignment of Assignor's Interest Oct 30, 2009

From: YOO, SANG-KU; KANG, KU SUK; YOO, SANG WOO; KWAK, TAEHWAN

To: MAZENCE INC.; KT & G CO., LTD.

Reel/Frame 023451/0305 →